SCHEMBL63676

SCHEMBL63676

CCCCCCCCCCCCC(O)COc1ccc([I+]c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4B P0C869 2/20 0.50
S1PR1 P21453 1/20 0.48
MAPT P10636 2/20 0.43
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPK1 P28482 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
LMNA P02545 2/20 0.42
TSHR P16473 1/20 0.42
POLB P06746 1/20 0.41
LTA4H P09960 1/20 0.41
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
CYP2D6 P10635 1/20 0.40
ADRB3 P13945 1/20 0.40
TBXA2R P21731 1/20 0.40
PTGER1 P34995 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4455826 1.00 PLA2G4B (0.50) PLA2G4BS1PR1MAPTHTTSMN1; SMN2
Hydrochloric Acid SCHEMBL31093484 0.99 PLA2G4B (0.49) PLA2G4BS1PR1MAPTHTTSMN1; SMN2
SCHEMBL29396017 0.95 PLA2G4B (0.46) PLA2G4BS1PR1MAPTHTTSMN1; SMN2
SCHEMBL29465911 0.95 PLA2G4B (0.46) PLA2G4BS1PR1MAPTHTTSMN1; SMN2
SCHEMBL225850 0.93 PLA2G4B (0.44) PLA2G4BS1PR1MAPTHTTSMN1; SMN2
SCHEMBL183916 0.92 PLA2G4B (0.46) PLA2G4BS1PR1MAPTHTTSMN1; SMN2
SCHEMBL1056070 0.90 PLA2G4B (0.42) PLA2G4BS1PR1MAPTHTTSMN1; SMN2
SCHEMBL5713078 0.89 S1PR1 (0.48) PLA2G4BS1PR1MAPTSMN1; SMN2NPC1
SCHEMBL30555138 0.89 PLA2G4B (0.41) PLA2G4BS1PR1MAPTHTTSMN1; SMN2
SCHEMBL30555112 0.89 PLA2G4B (0.41) PLA2G4BS1PR1MAPTHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565378-B1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2026-05-06 EP claimed
US-20260015799-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2026-01-15 US claimed
EP-4565378-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA Sicpa Holding SA (CH) 2025-06-11 EP claimed
US-12311406-B2 Methods for producing optical effect layers comprising magnetic or magnetizable pigment particles and exhibiting one or more indicia SICPA HOLDING SA (CH) 2025-05-27 US claimed
CN-119677597-A Method for producing an optical effect layer comprising magnetic or magnetizable pigment particles and exhibiting more than one marking 锡克拜控股有限公司 2025-03-21 CN claimed
US-20240238839-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2024-07-18 US claimed
WO-2024028408-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2024-02-08 WO claimed
EP-4313430-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA Sicpa Holding SA (CH) 2024-02-07 EP claimed
CN-117098610-A Method for producing an optical effect layer comprising magnetic or magnetizable pigment particles and exhibiting more than one marking 锡克拜控股有限公司 2023-11-21 CN claimed
EP-4208500-A1 POLYMERS CONTAINING REPEATING UNITS WITH SEVERAL METAL OR ORGANIC SULPHONATE UNITS, METHODS FOR PREPARING SAME AND USES THEREOF CDP-Innovation (FR) 2023-07-12 EP claimed
EP-2513722-B1 LED CURABLE LIQUID RESIN COMPOSITIONS FOR ADDITIVE FABRICATION, PROCESS FOR MAKING A THREE-DIMENSIONAL OBJECT USING THE SAME DSM IP ASSETS BV (NL) 2017-01-25 EP claimed
EP-1752463-B1 NOVEL FLUORINATED ALKYLFLUOROPHOSPHORIC ACID SALT OF ONIUM AND TRANSITION METAL COMPLEX SAN APRO LTD (JP) 2013-07-17 EP claimed
EP-2513722-A1 LED CURABLE LIQUID RESIN COMPOSITIONS FOR ADDITIVE FABRICATION DSM IP Assets B.V. (NL) 2012-10-24 EP claimed
US-20120259031-A1 LED CURABLE LIQUID RESIN COMPOSITIONS FOR ADDITIVE FABRICATION DSM IP ASSETS, B.V. (NL) 2012-10-11 US claimed
WO-2011075555-A1 LED CURABLE LIQUID RESIN COMPOSITIONS FOR ADDITIVE FABRICATION DSM IP ASSETS, B.V. (NL) 2011-06-23 WO claimed
EP-1673663-B1 LIGHT SENSITIVE COATING COMPOSITIONS FOR LITHOGRAPHIC ELEMENTS IBF IND BRASILEIRA DE FILMES SA (BR) 2011-03-23 EP claimed
US-7709598-B2 Fluorinated alkyl fluorophoshoric acid salts of onium and transition metal complex SAN-APRO LIMITED (JP) 2010-05-04 US claimed
US-20070225458-A1 Novel Fluorinated Alkyl Fluorophosphoric Acid Salts of Onium and Ttransition Metal Complex SAN-APRO LIMITED (JP) 2007-09-27 US claimed
EP-1752463-A1 NOVEL FLUORINATED ALKYLFLUOROPHOSPHORIC ACID SALT OF ONIUM AND TRANSITION METAL COMPLEX San-Apro Limited (JP) 2007-02-14 EP claimed
EP-1651731-B1 SOLVENTLESS, NON-POLLUTING RADIATION OR THERMALLY CURABLE COATINGS POLYSET COMP INC (US) 2006-11-22 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015799-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA IK, TEX10, INCENP PLA2G4B 3515/4885S1PR1 4351/4885MAPT 509/4885
US-20070225458-A1 Novel Fluorinated Alkyl Fluorophosphoric Acid Salts of Onium and Ttransition Metal Complex AS3MT, TTR, PFAS PLA2G4B 2296/4885S1PR1 2070/4885MAPT 641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.